WHO ICTRP trial
Influence of milk on erlotinib
EUCTR2016-001597-15-NL · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2016-001597-15-NL |
|---|---|
| Public title | Influence of milk on erlotinib |
| Scientific title | Influence of a fatty beverage (Milk) on the absorption of erlotinib: a randomized, cross-over pharmacokinetic study (MERLOT-study) |
| Primary sponsor | Erasmus MC cancer institute |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Netherlands |
| Conditions | Lung cancer;Therapeutic area: Diseases [C] - Cancer [C04] |
| Interventions | Trade Name: Tarceva Product Name: Tarceva Pharmaceutical Form: Tablet Trade Name: Nexium Product Name: Nexium Pharmaceutical Form: Tablet |
| Registration date | Apr 10, 2016 |
| Target size | 36 |
| Secondary IDs | MERLOT |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: